Cargando…
Benefit of OTC Formula Against COVID-19—Statistical Analysis Explained
Autores principales: | Margolin, Leon, Luchins, Jeremy, Margolin, Daniel, Margolin, Michelle, Lefkowitz, Sanford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724988/ https://www.ncbi.nlm.nih.gov/pubmed/34939460 http://dx.doi.org/10.1177/2515690X211058421 |
Ejemplares similares
-
20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment
por: Margolin, Leon, et al.
Publicado: (2021) -
Benefit of OTC Formula Against COVID-19 Is Explained by Selection Bias
por: Hemilä, Harri
Publicado: (2021) -
Licorice: A Potential Herb in Overcoming SARS-CoV-2 Infections
por: Ng, Swee Li, et al.
Publicado: (2021) -
Add-on Ayurveda Treatment for Early Stage COVID-19: A Single Center
Retrospective Cohort Study From Gujarat, India
por: Thakar, Anup, et al.
Publicado: (2021) -
Statistical studies in genetic toxicology: a perspective from the U.S. National Toxicology Program.
por: Margolin, B H
Publicado: (1985)